V
Vertex Pharmaceuticals
Creating Transformative Medicines
Boston, MA
5,000+
About Vertex Pharmaceuticals
Industry:
Biotechnology
Founded:
1989
Founders:
Joshua Boger, Kevin Kinsella
Status:
Public (NASDAQ: VRTX)
Funding & Growth
Total Raised:
N/A
Valuation:
$110B+ market cap
Stage:
Public
Key Investors:
Public markets
✓ Pros
- • CF drug success story
- • Strong financials
- • Boston Seaport location
- • Excellent benefits
- • Gene editing programs
✗ Cons
- • High expectations
- • CF franchise dependency
- • Competitive to get into
- • Fast-paced environment